PKM and colorectal carcinoma: These data further illustrated that ciRS‐122 could facilitate the expression of PKM2 as a sponge of miR‐122 at the posttranscriptional level, thereby accelerating glycolysis and lowering drug sensitivity in sensitive CRC cells.